Regeneron Pharmaceuticals Inc is to acquire Checkmate Pharmaceuticals Inc, a US oncology company with a clinical asset under investigation for the treatment of a number of cancers. Regeneron, which is a producer of antibody therapeutics, has built a pharmaceutical presence in a wide range of disease areas including inflammatory conditions, cardiovascular disease, pain, and cancer.
